74 / 2021-10-10 20:30:00
Discovery of Quinazolinone Derivatives as Novel Acetylcholinesterase (AchE) Inhibitors via Scaffold Hopping
Quinazolinone deviratives,AchE inhibitors,scaffold hopping
摘要录用
买买提明米热古丽 / Ocean University of China
吕凌 / Ocean University of China
陈淑霞 / Ocean University of China
孙艳凤 / Ocean University of China
黄炎 / Ocean University of China
李骅轩 / Ocean University of China
刘志清 / 中国海洋大学
王长云 / Ocean University of China
As the primary cause of dementia, Alzheimer’s disease (AD) is affecting more than 50 million people all over the world.1 Although there are four approved acetylcholinesterase (AchE) inhibitors and one N-methyl-D-aspartate (NMDA) receptor antagonist available in market, they can just provide modest symptomatic relief without blocking the progression of the disease let alone the side effects.2 Development of new more effective AchE inhibitors are still needed as safe and efficient AD therapeutics. Based on the co-crystal structure of Donepezil and AchE (PDB code: 6o4w),3 we designed a new series of quinazolinones (privileged scaffolds in marine natural products) as AchE inhibitors via a scaffold hopping strategy. Compounds MR2938 and MR2937 exhibited inhibitory activity against AchE with the IC50 values of 5.5 and 5.8 μM, respectively. Molecular docking study showed that MR2937 mimic Donepezil and occupy the active site very well, whereas different from Donepezil, multiple π-π stacking and cation-π interactions rather than hydrogen bonds were observed. This may explain their discrepancy on AchE inhibitions and give hints on how to improve the in vitro activities next step. Structural modifications and biological evaluations using orthogonal assays are ongoing.



Acknowledgements

This work was supported by the National Natural Science Foundation of China (Nos. 41830535; 4217060347; 81874300; 81673350), and the Taishan Scholars Program, China.

References:

  1. Hodson, R. Alzheimer's disease. Nature 2018, 559, S1.


2. Marucci, G.; Buccioni, M.; Ben, D. D.; Lambertucci, C.; Volpini, R.; Amenta, F. Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease. Neuropharmacology 2021, 190, 108352.

3. Gerlits, O.; Ho, K. Y.; Cheng, X.; Blumenthal, D.; Taylor, P.; Kovalevsky, A.; Radic, Z. A new crystal form of human acetylcholinesterase for exploratory room-temperature crystallography studies. Chem. Biol. Interact. 2019, 309, 108698.

 
重要日期
  • 会议日期

    11月12日

    2021

    11月14日

    2021

  • 11月14日 2021

    注册截止日期

主办单位
中国药学会海洋药物专业委员会
中国生物化学与分子生物学学会海洋专业分会
中国微生物学会海洋微生物学专业委员会
中国海洋湖沼学会药物分会
承办单位
广西中医药大学
联系方式
历届会议
移动端
在手机上打开
小程序
打开微信小程序
客服
扫码或点此咨询